Bifidobacterium bifidum

The type species of the genus — a live culture, counted by the billion

All articles checked for accuracy against the GB NHC Register and all sources have citations with verified links to their relevant studies.

A billion small cells with a long story. Bifidobacterium bifidum is the species that gave its name to the whole genus and remains a reference point for researchers and formulators.

This article explains what is specific to Bifidobacterium bifidum, how it is measured in supplements, what strain-level research exists and what it does not support. It clarifies regulatory limits on claims for bacterial species and describes how WellsparQ declares this live culture in its CapryGuard Complex.

Ingredient Snapshot

What it is

A species of live bacterial culture used as a named probiotic ingredient.

Where from

Bifidobacterium bifidum (type species of the genus Bifidobacterium).

Known for

A gut-associated bacterium notable for extracellular breakdown of complex sugars, including mucin glycans and human milk oligosaccharides.

For reference

• CapryGuard ComplexBifidobacterium Bifidus — 10 mg

Bifidobacterium bifidum is where the whole genus begins. When the French paediatrician Henri Tissier isolated a Y-shaped, forked bacterium from the stools of breastfed infants around 1900, he called it Bacillus bifidus communis — "bifidus" for the split, forked shape ^¹². That organism later gave its name to the genus Bifidobacterium, and B. bifidum remains its type species: the reference point against which the others are described ^¹. In a WellsparQ formula it is one named live culture among several, declared by weight and by count. This page explains what is specific to this species, and what the research on it does and does not show.

What sets B. bifidum apart

Bifidobacteria share a common toolkit. They are Gram-positive, non-spore-forming, non-motile, anaerobic bacteria with a high GC-content genome, and they ferment sugars through a distinctive route — the "bifid shunt" — using the marker enzyme fructose-6-phosphate phosphoketolase ^¹². They are among the first colonisers of the infant gut and a normal part of the adult gut community.

What makes B. bifidum itself distinctive is how it feeds. It is a specialist forager of complex sugars, and reviews describe it as notable for degrading both host mucin glycans and human milk oligosaccharides (HMOs) outside the cell, using surface-anchored enzymes ^¹. That extracellular breakdown releases sugars that other gut bacteria can then share — so B. bifidum is often described as a "cross-feeder" that supports a wider microbial community ^¹. It also carries surface structures linked to adhesion to the gut lining ^¹. These are described characteristics of the species, studied in the laboratory and in genomic surveys — not health promises.

What the named-strain research shows — and its limits

Effects reported for one strain do not carry across to another; strain identity matters. The most-studied B. bifidum strain is MIMBb75. In a randomised, double-blind, placebo-controlled trial, Guglielmetti and colleagues (2011) gave 122 adults with irritable bowel syndrome either MIMBb75 or placebo once daily for four weeks. Adequate relief of global IBS symptoms was reported by 47% of the MIMBb75 group versus 11% of the placebo group ^³. A later multicentre trial published in 2020 tested a heat-inactivated (non-living) form of the same strain in IBS ^⁴.

Two points of honesty belong here. First, these findings attach to MIMBb75 specifically, not to B. bifidum as a species, and not to any other strain. Second, the NHS notes that evidence for live-culture products overall is limited, and that shop-bought products may differ considerably from the graded material used in trials ^⁵. This is research context, not a claim about any WellsparQ product.

How a live culture is measured

Live cultures are counted, not just weighed. The working unit is the colony-forming unit (CFU) — the number of viable cells able to grow into a colony. A stated weight in milligrams and a stated count in CFU are different things: the milligram figure is the mass of the culture preparation (freeze-dried cells plus their carrier), while the CFU figure is how many living cells that mass is verified to deliver at manufacture.

In WellsparQ's CapryGuard Complex, B. bifidum is declared as "Bifidobacterium Bifidus — 10 mg", described on the factsheet card as "the second strain — another 100 million active cultures per capsule". So the 10 mg is the weighed addition, and 100 million (1 × 10⁸) is the live count it is standardised to provide. It sits alongside a first live culture in the same complex — a measured, named addition rather than a headline act.

Because live-culture counts fall over time, viability is a shelf-life question as much as a formulation one — storage as directed matters. The material is a bacterial culture grown on a fermentation medium; where suitability for vegan, kosher or halal diets is claimed, it follows the specific product record.

Suitability and sensible use

B. bifidum is a normal member of the human gut and has a long record of use in foods and supplements. As with any live-culture product, anyone who is pregnant, breastfeeding, seriously unwell, or immunocompromised should speak to a GP or pharmacist first ^⁵. Keep to the stated directions and storage.

In short

B. bifidum is the founding member of its genus and a genuine early-life gut specialist, best known scientifically for how it breaks down complex sugars and, in the strain MIMBb75, for IBS trials. WellsparQ's job is the plain one: name the species, count the culture, and let the evidence be read as evidence.